12-663453-T-C

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The ENST00000543884.2(NINJ2-AS1):​n.346T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000244 in 1,613,284 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00024 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00025 ( 2 hom. )

Consequence

NINJ2-AS1
ENST00000543884.2 non_coding_transcript_exon

Scores

16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.555
Variant links:
Genes affected
NINJ2-AS1 (HGNC:40405): (NINJ2 antisense RNA 1)
NINJ2 (HGNC:7825): (ninjurin 2) The protein encoded by this gene belongs to the ninjurin (for nerve injury induced) family. It is a cell surface adhesion protein that is upregulated in Schwann cells surrounding the distal segment of injured nerve, and promotes neurite outgrowth, thus may have a role in nerve regeneration after nerve injury. [provided by RefSeq, Oct 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0043171644).
BS2
High Homozygotes in GnomAdExome4 at 2 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NINJ2NM_016533.6 linkuse as main transcript upstream_gene_variant ENST00000305108.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NINJ2-AS1ENST00000543884.2 linkuse as main transcriptn.346T>C non_coding_transcript_exon_variant 3/33
NINJ2ENST00000662884.1 linkuse as main transcriptc.46A>G p.Lys16Glu missense_variant 1/4
NINJ2-AS1ENST00000662519.1 linkuse as main transcriptn.589T>C non_coding_transcript_exon_variant 3/3
NINJ2ENST00000305108.10 linkuse as main transcript upstream_gene_variant 1 NM_016533.6 P1

Frequencies

GnomAD3 genomes
AF:
0.000236
AC:
36
AN:
152238
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000468
AC:
117
AN:
249748
Hom.:
0
AF XY:
0.000459
AC XY:
62
AN XY:
135014
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00964
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000133
Gnomad OTH exome
AF:
0.000985
GnomAD4 exome
AF:
0.000245
AC:
358
AN:
1461046
Hom.:
2
Cov.:
31
AF XY:
0.000267
AC XY:
194
AN XY:
726854
show subpopulations
Gnomad4 AFR exome
AF:
0.0000598
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00997
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000414
Gnomad4 OTH exome
AF:
0.000812
GnomAD4 genome
AF:
0.000236
AC:
36
AN:
152238
Hom.:
0
Cov.:
33
AF XY:
0.000202
AC XY:
15
AN XY:
74378
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00864
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000567
Hom.:
1
Bravo
AF:
0.000219
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.000329
AC:
40
EpiCase
AF:
0.000218
EpiControl
AF:
0.000237

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 31, 2023The c.46A>G (p.K16E) alteration is located in exon 1 (coding exon 1) of the NINJ2 gene. This alteration results from a A to G substitution at nucleotide position 46, causing the lysine (K) at amino acid position 16 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
8.6
DANN
Benign
0.80
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.038
N
LIST_S2
Benign
0.33
T
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.0043
T
MetaSVM
Benign
-1.0
T
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.080
N
REVEL
Benign
0.011
Sift
Benign
0.14
T
Sift4G
Benign
0.27
T
Vest4
0.097
MVP
0.22
MPC
0.19
ClinPred
0.019
T
GERP RS
-1.6
gMVP
0.18

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs148175381; hg19: chr12-772619; API